NASOPHARYNGEAL CANCER
Clinical trials for NASOPHARYNGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CANCER trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy targets Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests an investigational cell therapy called P-MUC1C-ALLO1 in adults with advanced solid tumors (e.g., breast, ovarian, lung, pancreatic cancers) that have not responded to standard treatments. The main goals are to find a safe dose and check for early sign…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 03:19 UTC
-
New pill targets virus-driven cancer in patients with no other options
Disease control OngoingThis study tests a new drug called VK 2019 in 13 people with Epstein-Barr virus (EBV) positive nasopharyngeal cancer or other EBV-related cancers that cannot be cured with standard treatments. The drug works by blocking a key viral protein (EBNA1) that helps the cancer grow. The …
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated May 17, 2026 03:18 UTC
-
Immune cell therapy shows promise for advanced throat cancer
Disease control OngoingThis early-phase study tests whether a personalized immune cell treatment (dendritic cells) can safely help control advanced nasopharyngeal cancer. About 15 participants who have not fully responded to standard treatments will receive this therapy. The main goal is to see if it i…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated May 08, 2026 12:01 UTC